Atasoy Beste Melek, Özden Gülşah, Cinel Leyla, Gül Dilek, Yumuşakhuylu Ali Cemal, Akdeniz Doğan Zeynep
Department of Radiation Oncology, Marmara University School of Medicine, Istanbul, Türkiye.
Department of Medical Pathology, Marmara University School of Medicine, Istanbul, Türkiye.
Clin Transl Oncol. 2025 Jun;27(6):2651-2657. doi: 10.1007/s12094-024-03788-8. Epub 2024 Nov 29.
To examine the impact of the worst patterns of invasion (WPOI) on survival outcomes and possible implications for adjuvant treatment decisions in squamous cell oral cavity cancer patients.
The loco-regional progression-free survival (LRPFS) and the distant metastasis-free survival (DMFS) were calculated for 162 patients. Univariate and multivariate analyses were done according to prognostic predictors of stage (early/T1-2 or N0; locally advanced /T3-4 or N +), grade, depth of invasion, WPOI, perineural (PNI), and lymphovascular (LVI) invasion and margin status. WPOI-V, PNI, and LVI were also analyzed for their positive status.
The median follow-up was 46 months (3-77 months). A total of 32 events, as loco-regional (n = 16), systemic progression (n = 14), and second primary lung cancer (n = 2) were observed. The presence of locally advanced disease, PNI or LVI, and WPOI-V were significantly worse prognostic factors for LRFS and DMFS. The 5-year LRPFS (74% vs. 92.8%, p = 0.001) and DMFS (74% vs. 94%, p < 0.0001) were significantly worse in patients with WPOI-V present. In multivariate analysis, WPOI-V patients had a worse prognosis for loco-regional relapse (p = 0.037) in early-stage cancer. There were no triple-positive patients in the early-stage group. LRRFS (90.4% vs. 59.7%, p < 0.0001) and DMFS (97% vs. 42.9%, p = 0.013) were significantly better in triple-negative patients compared to triple-positive patients.
WPOI-V indicates a poor prognosis for locoregional progression and distant metastasis. Survival outcomes are significantly worse in triple-positive patients. These results need further evidence for adjuvant radiotherapy for early and systemic therapy for triple-positive locally advanced-stage patients.
探讨侵袭最差模式(WPOI)对口腔鳞状细胞癌患者生存结局的影响以及对辅助治疗决策的潜在意义。
计算162例患者的局部区域无进展生存期(LRPFS)和远处转移无进展生存期(DMFS)。根据分期(早期/T1-2或N0;局部晚期/T3-4或N+)、分级、浸润深度、WPOI、神经周围浸润(PNI)、脉管浸润(LVI)和切缘状态等预后预测因素进行单因素和多因素分析。还分析了WPOI-V、PNI和LVI的阳性状态。
中位随访时间为46个月(3-77个月)。共观察到32例事件,包括局部区域进展(n = 16)、全身进展(n = 14)和第二原发性肺癌(n = 2)。局部晚期疾病、PNI或LVI以及WPOI-V的存在是LRFS和DMFS显著更差的预后因素。存在WPOI-V的患者5年LRPFS(74%对92.8%,p = 0.001)和DMFS(74%对94%,p < 0.0001)显著更差。在多因素分析中,WPOI-V患者在早期癌症中局部区域复发的预后更差(p = 0.037)。早期组中没有三阳性患者。与三阳性患者相比,三阴性患者的LRRFS(90.4%对59.7%,p < 0.0001)和DMFS(97%对42.9%,p = 0.013)显著更好。
WPOI-V表明局部区域进展和远处转移的预后较差。三阳性患者的生存结局显著更差。这些结果需要进一步证据来支持早期辅助放疗和三阳性局部晚期患者的全身治疗。